<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03450499</url>
  </required_header>
  <id_info>
    <org_study_id>IRC/1089/017</org_study_id>
    <nct_id>NCT03450499</nct_id>
  </id_info>
  <brief_title>Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section</brief_title>
  <official_title>Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>B.P. Koirala Institute of Health Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>B.P. Koirala Institute of Health Sciences</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomized double blind study will be conducted in pregnant woman planned for non
      elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous
      0.25 mg/kg and placebo group will receive same amount of normal saline after spinal
      anesthesia prior to skin incision. Postoperative outcomes measures are total opioid
      consumption and pain scores for 24 hrs.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2018</start_date>
  <completion_date type="Anticipated">April 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total opioid requirement postoperatively</measure>
    <time_frame>24 hrs</time_frame>
    <description>Total opioid required up to 24 postoperatively in ketamine and placebo group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Postoperative numerator rating scores(NRS)up to 24 hrs . postoperative )</measure>
    <time_frame>24 hrs</time_frame>
    <description>• Postoperative NRS Scores (on arrival to Post operative care unit), 2, 4, 6, 8, 12 and 24 h ).The NRS ranges from 0- 10 and 0 refers to no pain and 10 means extreme possible pain perceived.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first opioid request</measure>
    <time_frame>24 hrs</time_frame>
    <description>Time to first opioid request</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of side effects</measure>
    <time_frame>24 hrs</time_frame>
    <description>Incidence of post operative nausea and vomiting, shivering, sedation scores, side effects related to ketamine during the first 24h</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Non Elective Cesarean Section and Ketamine Analgesia</condition>
  <arm_group>
    <arm_group_label>analgesic effects of ketamine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>the experimental group will receive ketamine intravenously at 0.25 mg per kg before skin incision.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>they will receive same volume of 0.9% normal saline as calculated for experimental group before skin incision.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ketamine</intervention_name>
    <description>the analgesic affects of ketamine will be compared between the experimental and placebo group.</description>
    <arm_group_label>analgesic effects of ketamine</arm_group_label>
    <other_name>ketamine hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>the analgesic requirement will be calculated in placebo group.</description>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • All women at term(&gt;or =37 weeks of gestation)

               -  Healthy

               -  American Society of Anesthesiologists(ASA) class1 and 2

               -  Women undergoing non-elective caesarean section whose anesthetic plan is for
                  spinal anesthesia with bupivacaine and fentanyl

        Exclusion Criteria:

          -  • Women with American society of anesthesiologist physical status&gt;2

               -  Body mass index &gt;or =40 kg per square meter

               -  Height &lt;150 cm

               -  Any contraindication to the spinal anesthesia

               -  History of substance abuse

               -  History of hallucinations

               -  Chronic opioid therapy

               -  Chronic pain or on any pain medication currently

               -  Patient with maternal complications,like cardiovascular disease
                  pre-eclampsia,diabetes,multiple gestation,known fetal abnormality

               -  Cases with severely compromised fetus where immediate administration of general
                  anesthesia is required.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>prahlad adhikari, graduate</last_name>
    <phone>9779851228244</phone>
    <email>pra_adhikari@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>BP Koirala Institute of Health Sciences (BPKIHS)</name>
      <address>
        <city>Dharan</city>
        <state>Sunsari</state>
        <zip>56700</zip>
        <country>Nepal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Prahlad Adhikari, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 18, 2018</study_first_submitted>
  <study_first_submitted_qc>February 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2018</study_first_posted>
  <last_update_submitted>April 2, 2018</last_update_submitted>
  <last_update_submitted_qc>April 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>B.P. Koirala Institute of Health Sciences</investigator_affiliation>
    <investigator_full_name>prahlad adhikari</investigator_full_name>
    <investigator_title>doctor</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ketamine</mesh_term>
    <mesh_term>Analgesics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

